Edgewise Therapeutics’ (EWTX) Overweight Rating Reiterated at Piper Sandler
Piper Sandler reaffirmed their overweight rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently has a $51.00 price target on the stock. Several other analysts have also recently commented on the stock. Evercore ISI raised their target price on shares of Edgewise […]
Piper Sandler reaffirmed their overweight rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently has a $51.00 price target on the stock. Several other analysts have also recently commented on the stock. Evercore ISI raised their target price on shares of Edgewise […]
